Efficacyand Safety of Palbociclib (PAL) PUS Fulvestrant (F) by Geographic Region in Women with Endocrine-Resistant Hormone Receptor-Positive (HR+), Human Epiderman Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) from Paloma-3. (November 2017) - Harbeck, Nadia; Colleoni, Marco; Demichele, Angela; Turner, Nicholas C.; Cristofanilli, Massimo; Verma, Shailendra; Sleckman, Bethany; Huang, Xin; Theall, Kathy Puyana; Bananis, Eustratios; Masuda, Norikazu; Im, Seock-Ah